Nutrition/Agriculture News From Medical News Today
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader, such as GoogleReader, or to display this data on your own website or blog. 
Subscribe to this data using MyMedWorm.
Subscribe to this data using GoogleReader.
Subscribe to this data using Bloglines.
Subscribe to this data using MyYahoo.
Get the very latest Swine Flu news via the MedWorm Swine Flu RSS news feed - updated hourly from thousands of authoritative health and news sources.
This page shows you the latest items in this publication.
642894 records returned
Hypertrophic cardiomyopathy and athlete's heart: a tale of two entities.
Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
We report the case of a 17-year-old football player with a pathological electrocardiography (ECG) in the pre-participation screening programme, highly suggestive of HCM, in which ECG study showed a septum thickness of 28 mm. Genetic analysis revealed R 495 W mutation in the 18 exon of the MyBPC3 (myosin-binding protein C) and sports activities were contraindicated. Two years later, septum thickness was 19.5 mm. Usefulness of 12-lead ECG, differential diagnosis between athlete's heart and HCM, and the stratification in patients with HCM are discussed.
PMID: 18713777 [PubMed - as supplied by publisher]
Source: European Journal of Echocardiography - August 18, 2008 Category: Cardiology Authors: Martín M, Reguero JJ, Castro MG, Coto E, Hernández E, Carro A, Calvo D, Morí de la Tassa C Tags: Eur J Echocardiogr Source Type: journals
Thailand: alcohol todayEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Addiction Volume 101, Issue 6, Page 783-787, Jun 2006
Source: Addiction - May 12, 2006 Category: Addiction Source Type: journals
A longitudinal evaluation of medical student knowledge, skills and attitudes to alcohol and drugsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Addiction Volume 101, Issue 6, Page 841-849, Jun 2006
Source: Addiction - May 12, 2006 Category: Addiction Source Type: journals
News and NotesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Addiction Volume 101, Issue 6, Page 905-907, Jun 2006
Source: Addiction - May 12, 2006 Category: Addiction Source Type: journals
Alexion Pharmaceuticals' Antibody Therapy Shown Effective In Model For Severe Allergic AsthmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AlexionPharmaceuticals, Inc. (Nasdaq: ALXN) today announced research findings showing that its anti-C5 monoclonal antibody can be effectively delivered to the lungs to substantially block airway inflammation andhyperresponsiveness in preclinical models of acute severe allergic asthma. The compound used in the research is a surrogate of eculizumab, Alexion's lead anti-complement antibody. [click link for full article]
Source: Allergy News From Medical News Today - May 16, 2006 Category: Allergy & Immunology Source Type: news
Overcoming Allergy To Clopidogrel, Life-saving Anti-clotting MedicationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A careful desensitization protocol can help patients overcome allergic reactions to anti-clotting medication critical to preventing new blockages inside coronary stents, according to a study being presented at the Society for Cardiovascular Angiography and Interventions (SCAI) 29th Annual Scientific Sessions in Chicago, May 10-13. (Time of Presentation: Thursday, May 11, 10:39 a.m. Central Time). [click link for full article]
Source: Allergy News From Medical News Today - May 14, 2006 Category: Allergy & Immunology Source Type: news
Allergy/asthma And Cystic Fibrosis (CF) Focus Of Awareness In MayEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
New research initiatives announced just in time for both Allergy/Asthma and Cystic Fibrosis (CF) Awareness Months will focus on developing a better understanding of the ways in which people respond to exposure to infectious agents in the lungs.Understanding the role of the immune system in lung disease is the focus of new research projects funded through a $4. [click link for full article]
Source: Allergy News From Medical News Today - May 13, 2006 Category: Allergy & Immunology Source Type: news
Europe Wide Study To Examine Causes Of AsthmaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Imperial College London and Ludwig-Maximilians-Universität (LMU) Munich are to take the lead in a Euro 11 million (GBP 8 million) study to examine how genetics and environment influence the development of asthma in Europe. [click link for full article]
Source: Allergy News From Medical News Today - May 11, 2006 Category: Allergy & Immunology Source Type: news
Halting Histamine Action May Lead To Relief For Allergic Disease SufferersEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In allergic diseases such as asthma, hay fever, and rhinitis an allergen stimulates the release of antibodies that attach themselves to mast cells causing these cells to release histamine, which can cause symptoms like itching of the nose, skin and eyes, sneezing, and wheezing. The characteristic "Th2 immune response" observed in allergy sufferers is an acquired immune response whose most prominent feature is high antibody production relative to the amount of cytotoxic T cells. [click link for full article]
Source: Allergy News From Medical News Today - May 8, 2006 Category: Allergy & Immunology Source Type: news
Asthma UK Launches First Ever Asthma Control CensusEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Asthma UK is launching its first ever asthma control census today, World Asthma Day 2006, to raise awareness amongst the 5.2 million people with asthma in the UK that they may be putting up with symptoms that impact unnecessarily on their quality of life. The charity is calling on people with asthma to complete the Asthma Control Test™, a 60-second, five-point questionnaire that will help them to understand how well their asthma is controlled. [click link for full article]
Source: Allergy News From Medical News Today - May 8, 2006 Category: Allergy & Immunology Source Type: news
Unique Soybean Lines Hold Promise For Producing Allergy-free SoybeansEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Researchers have isolated two Chinese soybean lines that grow without the primary protein linked to soy allergies in children and adults. The two lines already are adapted to Illinois-like conditions and will be given away to breeders seeking to produce new varieties of allergy-free soybeans without genetic engineering.Crop scientists at the University of Illinois at Urbana-Champaign and the USDA-Agricultural Research Service's Donald Danforth Plant Science Center in St. [click link for full article]
Source: Allergy News From Medical News Today - May 7, 2006 Category: Allergy & Immunology Source Type: news
Atchoo! 'Tis The Season For Sneezing - NewYork-Presbyterian Specialists Offer Advice On Coping With AllergiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Itchy, watery eyes. Stuffy nose. Sneezing. Sound familiar? As much as we love it, warm weather can spell misery for the 20 to 30 million Americans who suffer from allergies. According to Dr. Rachel Miller, Assistant Professor of Clinical Medicine and Public Health, NewYork-Presbyterian Hospital/Columbia University Medical Center, the majority of spring respiratory problems come from inhaling such allergens as trees or grass pollen and mold spores. [click link for full article]
Source: Allergy News From Medical News Today - April 6, 2006 Category: Allergy & Immunology Source Type: news
UC Davis Study With Mice Links Thimerosal With Immune System DysfunctionEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A team of cell biologists, toxicologists and molecular bioscientists at the University of California, Davis, has published a study connecting thimerosal with disruptions in antigen-presenting cells known as dendritic cells obtained from mice. The study provides the first evidence that dendritic cells show unprecedented sensitivity to thimerosal, resulting in fundamental changes in the immune system's ability to respond to external factors. [click link for full article]
Source: Allergy News From Medical News Today - March 22, 2006 Category: Allergy & Immunology Source Type: news
Do You Have Concerns About Asthma Treatments?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Asthma UK is seeking help from people with asthma in identifying the most common concerns they have about their treatments, in order to help prioritise research. This work is a partnership between Asthma UK, the British Thoracic Society and the James Lind Alliance. The aim is for people with asthma and clinicians to agree priority areas of research about asthma treatments. [click link for full article]
Source: Allergy News From Medical News Today - March 22, 2006 Category: Allergy & Immunology Source Type: news
Spring Fever: Great For The Soul But Tough Times For Asthma & AllergiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
As winter-weary Americans burst outdoors to exercise, play and dig into yard work, and student athletes' training transitions back out to fresh Spring air, millions of people may be at risk for flare-ups of lung disease due to high pollen levels and/or outdoor air pollution that can reach unhealthy levels any day. [click link for full article]
Source: Allergy News From Medical News Today - March 22, 2006 Category: Allergy & Immunology Source Type: news
New Guidelines Reveal The Complexity Of Food Allergy ManagementEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Allergists representing three organizations developed evidence-based guidelines for food allergy diagnosis and management, which has become more sophisticated and challenging in recent years due to the increase in prevalence of certain food allergies and important scientific developments. [click link for full article]
Source: Allergy News From Medical News Today - March 21, 2006 Category: Allergy & Immunology Source Type: news
GA2LEN - Global Allergy And Asthma European Network - Press Conference & Plenary Session - Media InvitationEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
WHAT? Press Conference (10:00-11:00), followed by session "Allergy throughout life - GA2LEN in action"(11:00-13:30) WHEN? 31 March 2006 - Press Conference (10.00-11.00), Session "Allergy throughout life - GA2LEN in action" (11.00-13. [click link for full article]
Source: Allergy News From Medical News Today - March 18, 2006 Category: Allergy & Immunology Source Type: news
Eurand's AdvaTab Cetirizine Successfully Meets Major Development MilestoneEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Eurand, aspecialty pharmaceutical company, today reported the achievement of a majormilestone in the development program for its AdvaTab(R) formulation ofcetirizine, a leading prescription antihistamine sold in the United States andother markets as Zyrtec(R). AdvaTab Cetirizine is a taste-masked, stabilizedformulation that utilizes Eurand's proprietary Microcaps tastemasking andAdvaTab orally disintegrating tablet (ODT) technologies. [click link for full article]
Source: Allergy News From Medical News Today - March 16, 2006 Category: Allergy & Immunology Source Type: news
Soy Sauce Bacteria Effective Against AllergiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Tokyo, (JCN) - Kikkoman Corporation has discovered that lactic acid bacteria derived from soy sauce and other fermented foods are effective against allergies. Specifically, the company has elucidated that tetragenococcus halophilus Th221, a kind of plant-derived lactic acid bacteria found in soy sauce, can induce the generation of interleukin 12 (IL-12), a substance that helps alleviate allergic symptoms. [click link for full article]
Source: Allergy News From Medical News Today - March 11, 2006 Category: Allergy & Immunology Source Type: news
Greer's Sublingual-Oral Immunotherapy Clinical Trials Support The Safety Of Home Administration Of Allergy ImmunotherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Greer reported results of PhaseI safety and dosing trials for the sublingual-oral immunotherapyadministration of its standardized dust mite, short ragweed, Timothy grass andcat hair extracts at the American Academy of Allergy Asthma and Immunology(AAAAI) annual meeting. Dr. [click link for full article]
Source: Allergy News From Medical News Today - March 7, 2006 Category: Allergy & Immunology Source Type: news
Advances In Food Allergy Research Presented At 2006 AAAAI Annual Meeting In Miami BeachEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Peanut allergic people,particularly teenagers, need to know the risks of kissing someone who hasrecently eaten peanut, even if they brushed their teeth, according to a newstudy presented today at the 2006 Annual Meeting of the AAAAI in Miami Beach. Jennifer M. Maloney, MD, Mount Sinai Medical Center, New York, NY, andcolleagues looked to find out how much peanut allergen was in saliva followinga meal. [click link for full article]
Source: Allergy News From Medical News Today - March 7, 2006 Category: Allergy & Immunology Source Type: news
Infection 'Alarm' Yields Clues To Immune System BehaviorEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Drawing on lab experiments and computer studies, Johns Hopkins researchers have learned how a common protein delivers its warning message to cells when an infectious agent invades the body. The findings are important because this biological intruder alarm causes the body's immune system to leap into action to fight the infection. [click link for full article]
Source: Allergy News From Medical News Today - March 5, 2006 Category: Allergy & Immunology Source Type: news
FAAN To Discuss Risk-Taking And Coping Strategies Of Teens With Food Allergies At The AAAAI Annual ConferenceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Food Allergy & AnaphylaxisNetwork (FAAN) will reveal findings of a study that could give significantinsight on what may cause teens to be a high risk group for fatal allergicreactions to food. These findings will be presented on Monday, March 6, atthe American Academy for Allergy, Asthma and Immunology (AAAAI) AnnualConference in Miami, Fla. A press conference will be held at 11:00am at theMiami Beach Convention Center, Room B117. [click link for full article]
Source: Allergy News From Medical News Today - March 3, 2006 Category: Allergy & Immunology Source Type: news
Preliminary Results From Largest Allergy Study Of Its Kind To Be Released Monday, February 27, 2006Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The results, endorsed by the AmericanCollege of Allergy, Asthma & Immunology, are in. [click link for full article]
Source: Allergy News From Medical News Today - February 26, 2006 Category: Allergy & Immunology Source Type: news
Allergic Rhinitis - Alcon Laboratories (UK) Ltd Withdraws Its Application To Extend The Marketing Authorisation For OpatanolEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The European Medicines Agency was formally notified by Alcon Laboratories (UK) Ltd of its decision to withdraw its application for an extension of the marketing authorisation for the medicinal product Opatanol (Olopatadine hydrochloride). Opatanol was first authorised in the European Union on 17 May 2002 as eye drops for the treatment of ocular signs and symptoms of seasonal allergic conjunctivitis. [click link for full article]
Source: Allergy News From Medical News Today - February 24, 2006 Category: Allergy & Immunology Source Type: news
FDA Approves First Generic Version Of FlonaseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The Food and Drug Administration (FDA) today approved Fluticasone Propionate Nasal Spray, the first generic version of the brand name drug Flonase, giving American consumers an additional, lower cost alternative when choosing prescription drug products. "Except for their price, which is much lower, generic drugs are in every way equivalent to their brand name counterparts," said Dr. Steven Galson, Director of FDA's Center for Drug Evaluation and Research. [click link for full article]
Source: Allergy News From Medical News Today - February 23, 2006 Category: Allergy & Immunology Source Type: news
No Difference Between Over-the-counter And Prescription Drug In Relieving Seasonal AllergiesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A small study indicates that there was no difference between an over-the-counter decongestant (pseudoephedrine) and a prescription medication (montelukast) in relieving symptoms associated with allergic rhinitis and improving quality of life, according to a study in the February issue of Archives of Otolaryngology - Head & Neck Surgery, one of the JAMA/Archives journals. [click link for full article]
Source: Allergy News From Medical News Today - February 22, 2006 Category: Allergy & Immunology Source Type: news
Expert Says McDonald's Fries Are 'Gluten And Allergen Free'Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
According to a McDonald's press release, an expert says their Fries are Gluten and Allergen Free. The press release goes on to say that McDonald's understands the concern that individuals in the Celiac community and others with food allergies may have regarding foods that meet their individual needs. According to Dr. Steven Taylor, Food Allergy Research and Resource Program, University of Nebraska, McDonald's Fries are gluten free and allergen free. [click link for full article]
Source: Allergy News From Medical News Today - February 21, 2006 Category: Allergy & Immunology Source Type: news
McDonald's Australia French Fries Free Of Wheat And MilkEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
According to a source in Australia who wrote to Medical News Today, wheat and milk is not used in the production of McDonald's Australia's French fries. Australia's laws on providing product information is a lot stricter than has been the case in the USA. Just because wheat and milk has been used in the production of McDonald's French fries in the USA does not necessarily mean this is the case all over the world. It depends on the laws of each country. [click link for full article]
Source: Allergy News From Medical News Today - February 21, 2006 Category: Allergy & Immunology Source Type: news
What Is Gluten Intolerance, Or Celiac Disease?Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Gluten intolerance is also known as Celiac disease. Quite simply, if you suffer from Celiac disease you have a genetic disorder that makes you allergic to gluten. Celiac disease can affect all types of people. However, it seems to be more prevalent among people of Northern European descent. In the USA about 1 in 133 people suffer from Celiac disease. [click link for full article]
Source: Allergy News From Medical News Today - February 21, 2006 Category: Allergy & Immunology Source Type: news
Fury At Milk And Wheat In McDonalds' French FriesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
When McDonalds serves its French Fries, everyone believes they contain just potatoes and cooking oil - even people who are vegan (eat no animal product at all) or allergic to wheat. We trust the company and believe everything they say. Because that is what they have been saying - that their fries are gluten-free. It has been revealed that McDonald's fries do contain an animal product - Milk. They also contain wheat. [click link for full article]
Source: Allergy News From Medical News Today - February 20, 2006 Category: Allergy & Immunology Source Type: news
'Nano-keys' Bind Cell Receptors And Trigger The Release Of Histamines In An Allergic ResponseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The tumblers of life continue to click as Cornell University researchers have fabricated a set of "nano-keys" on the molecular scale to interact with receptors on cell membranes and trigger larger-scale responses within cells -- such as the release of histamines in an allergic response.How cell membranes control cellular function has long been studied but with ambiguous results. [click link for full article]
Source: Allergy News From Medical News Today - February 20, 2006 Category: Allergy & Immunology Source Type: news
Preventing The Unwanted Side Effects Of Autoimmune Disease TherapyEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Treatment for autoimmune and inflammatory disorders such as multiple sclerosis often includes blocking a special cell surface attachment molecule known as alpha4 integrin to prevent migration of white blood cells (WBCs). However, this therapy can cause adverse side effects, such as impaired immunity and hematopoiesis [the process of development of new WBCs in the thymus (T cells) and bone marrow (B cells)]. Now, researcher Mark H. [click link for full article]
Source: Allergy News From Medical News Today - February 10, 2006 Category: Allergy & Immunology Source Type: news
FDA Approves CLARINEX-D(R) 12 HOUR (desloratadine 2.5mg/pseudoephedrine 120mg) Tablet Prescription Antihistamine With DecongestantEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Schering-Plough Corporation (NYSE: SGP) today announced that the U.S. Food and Drug Administration (FDA) has approved CLARINEX-D® 12 HOUR (desloratadine 2.5 mg and pseudoephedrine sulfate, USP 120 mg) Extended Release Tablets for the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis (outdoor allergies), including nasal congestion, in patients 12 years of age and older. [click link for full article]
Source: Allergy News From Medical News Today - February 6, 2006 Category: Allergy & Immunology Source Type: news
Healthy Human Immune System Cells Can Respond To HIV-1 - Findings Offer Hope For Vaccine Against AIDSEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
AIDS patients' failure to clear HIV-1 might not be due to the inability of the human immune system to recognise the virus, as was previously thought. A study published today in the open access journal Medical Immunology shows that cultured immune system cells taken from healthy individuals recognise and respond to HIV-1 proteins. Cells taken from infected individuals, however, are much less responsive to the virus. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 19, 2006 Category: Allergy & Immunology Source Type: news
'Bubble Bassets' Cured Of Genetic Disorder By In-vivo Gene Therapy TechniqueEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
In-vivo gene therapy successfully restored the immune system in basset pups with X-linked severe combined immunodeficiency, or XSCID, a life-threatening genetic disorder that effectively disables the immune system. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 18, 2006 Category: Allergy & Immunology Source Type: news
12 Million Euros From The European Commission For 'RUBICON'Email this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The European Commission in Brussels has awarded a 12 Million Eurogrant to foster the collaboration of European experts in the field ofUbiquitin research. The Ubiquitin system plays a crucial role inimportant cellular processes such as the removal of proteins no longerrequired or insufficiently constructed, the regulation of the cell cycle,immune response, and the repair of DNA. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 17, 2006 Category: Allergy & Immunology Source Type: news
Infamous Proto-oncogene, C-myc, Turns Up In A New RoleEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
c-myc, a gene commonly involved in cancer onset, has been found to have a role in the immune system's normal function according to a study published in the journal, Blood. The surprising finding, by a Swiss research team led by investigators from the Lausanne Branch of the international Ludwig Institute for Cancer Research (LICR), showed that c-myc functions in the immune system's 'memory' of previous infections. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 15, 2006 Category: Allergy & Immunology Source Type: news
Positive Results For ACRUX's Lead Product In US Phase 3 TrialEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Acrux (ASX: ACR), the pharmaceutical company with unique technology for delivering drugs through the skin, today announced positive results in a US Phase 3 clinical trial of Evamist, its daily skin spray for prevention of symptoms associated with menopause. The trial was conducted by its US commercial partner VIVUS Inc. (NASDAQ: VVUS), which will now proceed to file a marketing application with the US Food and Drug Administration (FDA) in the second half of 2006. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 14, 2006 Category: Allergy & Immunology Source Type: news
Interfering RNA Silences Genes In 'slippery' Immune CellsEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A technical advance in laboratory techniques may provide biology researchers broader access to RNA interference, a process of blocking the activity of targeted genes. RNA interference has recently emerged as an important tool in studying how genes function in normal biological processes and in disease. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 13, 2006 Category: Allergy & Immunology Source Type: news
Adjuvanted Formulation Of Sanofi Pasteur H5N1 Pandemic Influenza Vaccine Candidate Demonstrates Significant Immune ResponseEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A study published onlinein The Lancet on May 11 demonstrated that multiple dosage formulations of acandidate H5N1 influenza vaccine developed by sanofi pasteur were well-tolerated and generated an immune response, with and without adjuvant. Ofthe formulations being tested, an alum-adjuvanted 30 microgram dosagegenerated the most substantive immune response (66. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 13, 2006 Category: Allergy & Immunology Source Type: news
HIV Vaccinations In Trial Discontinued, Study Will Continue, Project Director SaysEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Joseph Makhema, project director at the Botswana-Harvard School of Public Health AIDS Initiative Partnership for HIV Research and Education, on Thursday announced that vaccinations in the Phase I HIV vaccine trial of AVX101 have been discontinued, AllAfrica.com reports (Chwaane, AllAfrica.com, 5/5). South Africa's [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 12, 2006 Category: Allergy & Immunology Source Type: news
Knowledge Of Dendritic Cells Branches OutEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A new type of cell that generates crucial cells of the immune system has been discovered at The Walter and Eliza Hall Institute. With this new knowledge, medical researchers can begin to consider the development of customized immune therapies using this new cell to target specific infections such as HIV, malaria and influenza; certain cancers; and even autoimmune diseases. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 11, 2006 Category: Allergy & Immunology Source Type: news
Immune System Protein Makes HIV More Infectious In Humans, Study SaysEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
"Cyclophilin A Renders Human Immunodeficiency Virus Type 1 Sensitive to Old World Monkey but Not Human TRIM5 Antiviral Activity," Journal of Virology: Greg Towers of [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 11, 2006 Category: Allergy & Immunology Source Type: news
New Treatment Against Persistent Ulcer-inducing Bacteria SuccessfulEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
For those who suffer from stomach ulcers, the daily routine of breakfast, lunch and dinner can be painful. A common cause of these ulcers, as well as other gastric malignancies, is a bacterium called Helicobacter pylori. For some, this infection can be persistent and difficult to treat.Many approaches have been taken in an attempt to clear such infections, but with limited or unsuccessful outcomes. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 10, 2006 Category: Allergy & Immunology Source Type: news
Improvement Of The Treatments Against Brucellosis And Ovine SalmonellaEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
Maite Estevan Muguerza, a researcher of the University of Navarra, has improved existing treatments against brucellosis and sheep salmonella, by applying, in her doctoral thesis, techniques of micro- and nano-technology which permit the encapsulation of vaccines.In this way the sustained liberation of the vaccine or antigenic compound is assured, so that it remains active in the body of the animal over the period of at least six months". [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 10, 2006 Category: Allergy & Immunology Source Type: news
New Study Reveals Structure Of E. Coli Multidrug Transporter Protein And Could Help Fight Multidrug ResistanceEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
This new study could potentially help researchers find new ways to avoid the problem of multidrug resistance and enhance the potency of existing drug compounds.The study is being published in ScienceXpress, an advance online edition of the journal Science, in May."The development of antibiotics to treat infectious disease is being seriously undermined by the emergence of drug-resistant bacteria," says Geoffrey A. Chang, Ph.D. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 9, 2006 Category: Allergy & Immunology Source Type: news
Interfering RNA Silences Genes In 'Slippery' Immune Cells -- Novel Lab Technique Expands Researchers' ToolboxEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
A technical advance in laboratorytechniques may provide biology researchers broader access to RNAinterference, a process of blocking the activity of targeted genes. RNAinterference has recently emerged as an important tool in studying howgenes function in normal biological processes and in disease. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 9, 2006 Category: Allergy & Immunology Source Type: news
European Medicines Agency Finds No Signal For Decreased Effectiveness Of HBVAXPRO And ProcomvaxEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
The European Medicines Agency concluded a review of HBVAXPRO and Procomvax, two centrally authorised vaccines (Marketing Authorisation Holder is Sanofi Pasteur MSD), saying that these vaccines continue to offer effective protection against hepatitis B. The review conducted by the Committee for Medicinal Products for Human Use (CHMP) was started in February 2006 at the request of the European Commission in order to assess the benefit of HBVAXPRO and Procomvax. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 9, 2006 Category: Allergy & Immunology Source Type: news
Targeted Virus Compels Cancer Cells To Eat ThemselvesEmail this article to a colleague.
Save this article to My Clippings.
Discuss or comment on this article.
An engineered virus tracks down and infects the most common and deadly form of brain cancer and then kills tumor cells by forcing them to devour themselves, researchers at The University of Texas M. D. Anderson Cancer Center report this week in the Journal of the National Cancer Institute. [click link for full article]
Source: Immune System / Vaccines News From Medical News Today - May 6, 2006 Category: Allergy & Immunology Source Type: news
